Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: May 4, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | $907.21B | 0.65% | 22.10% | $1.7300 | $6.23 | 14% | 0 | ||
| GILD | GILEAD SCIENCES INC | $163.43B | 2.42% | 46.20% | $0.8200 | $3.19 | 53% | 0 | ||
| CAH | CARDINAL HEALTH INC | $45.73B | 1.05% | 31.10% | $0.5107 | $2.04 | 25% | 0 | ||
| DXCM | DEXCOM INC | $23.67B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| THC | TENET HEALTHCARE CORP | $15.79B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JLL | JONES LANG LASALLE INC | $14.63B | N/A | 0.00% | $0.4300 | N/A | N/A | 0 | ||
| LEVI | LEVI STRAUSS & CO | $8.57B | 2.51% | 35.00% | $0.1400 | $0.56 | 55% | 2 | 2026-05-06 | |
| BCO | BRINKS CO | $4.42B | 0.95% | 21.60% | $0.2550 | $1.02 | 23% | 0 | 2026-05-18 | 2026-06-01 |
| AMRX | AMNEAL PHARMACEUTICALS INC | $4.04B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KTB | KONTOOR BRANDS INC | $3.99B | 2.91% | 51.00% | $0.5300 | $2.10 | 62% | 1 | 2026-06-08 | 2026-06-18 |
| LIVN | LIVANOVA PLC | $3.34B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DBD | DIEBOLD NIXDORF INC | $2.70B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCYT | VERACYTE INC | $2.63B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ATRO | ASTRONICS CORP | $2.54B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HLIO | HELIOS TECHNOLOGIES INC | $2.21B | 0.58% | 24.70% | $0.1200 | $0.39 | 12% | 1 | ||
| HCI | HCI GROUP INC | $1.98B | 1.05% | 4.90% | $0.4000 | $1.60 | 25% | 0 | 2026-05-15 | 2026-06-18 |
| INVA | INNOVIVA INC | $1.71B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | $1.30B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PHAR | PHARMING GROUP NV | $1.19B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INR | INFINITY NATURAL RESOURCES INC | $1.03B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MNTN | MNTN INC | $749.07M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | $628.04M | 3.36% | N/A | $0.2800 | $0.57 | 69% | 2 | ||
| NATR | NATURES SUNSHINE PRODUCTS INC | $466.75M | N/A | 0.00% | $1.0000 | N/A | N/A | 0 | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | $434.16M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PKOH | PARK OHIO HOLDINGS CORP | $410.95M | 1.75% | 28.90% | $0.1250 | $0.50 | 40% | 0 | 2026-05-15 | |
| ELMD | ELECTROMED INC | $211.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INFU | INFUSYSTEM HOLDINGS INC | $209.63M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PMTS | CPI CARD GROUP INC | $199.18M | N/A | 0.00% | $0.2250 | N/A | N/A | 0 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.